MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
The Lancet Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

832 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
832 works in the cohort · of 4,299,418page 13 of 17

Labels cover 9 of 832 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 832 of 832 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Sarcoma and germ-line DICER1 mutations
Leanne de Kock, William D. Foulkes
2016· letter· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
15
citations
affno abstractunlabeled
Genomic biomarkers for precision radiation medicine
Scott V. Bratman, Michael Milosevic, Fei‐Fei Liu, Benjamin Haibe‐Kains
2017· letter· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
14
citations
affno abstractunlabeled
A critique of the fragility index
Alexandra Desnoyers, Michelle B. Nadler, Brooke E. Wilson, Eitan Amir
2019· letter· en· The Lancet Oncology· Mathematics
machine prediction:candidate · metaresearchconsensus · none
13
citations
affno abstractunlabeled
Phosphenes in patients receiving radiotherapy
Juliette Thariat, Cecília Leal, Alessander D’Ascoli, P. Jardel, Jean‐Pierre Caujolle, J. Hérault +3 more
2016· article· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
13
citations
affno abstractunlabeled
Navigating prostate cancer control in Nigeria
Runcie C.W. Chidebe, Charles T. Orjiakor, Ian Pereira, Sampson Chinonso Ipiankama, David W. Lounsbury, Fábio Ynoe de Moraes
2019· article· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
13
citations
affno abstractunlabeled
Measuring value and benefit—a matter of perspective
William K. Evans, Matthew C. Cheung, Kelvin Chan
2017· letter· en· The Lancet Oncology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
12
citations
affno abstractunlabeled
SARS-CoV-2 vaccination and phase 1 cancer clinical trials
Timothy A. Yap, Lillian L. Siu, Emiliano Calvo, Martijn P. Lolkema, Patricia LoRusso, Jean‐Charles Soria +4 more
2021· article· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
12
citations
affno abstractunlabeled
Immunotherapy in renal cell carcinoma
Vishal Navani, Daniel Y.C. Heng
2023· letter· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
11
citations
affno abstractunlabeled
Improving affordability of new Essential Cancer Medicines
Ellen ‘t Hoen, Salomé Meyer, Patrick Durisch, Wilbert Bannenberg, Katrina Perehudoff, Tim Reed +1 more
2019· article· en· The Lancet Oncology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
9
citations
affno abstractunlabeled
Precision medicine for children with cancer
Ian F. Tannock
2023· article· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
8
citations
affno abstractunlabeled
The future of precise cancer chronotherapeutics
Pasquale F. Innominato, Abdoulaye Karaboué, Mohammed Bouchahda, Georg A. Bjarnason, Françis Lévi
2022· letter· en· The Lancet Oncology· Neuroscience
machine prediction:candidate · noneconsensus · none
8
citations
← previousnext →

How this was built: Screen · Findings · About